Acute Respiratory Distress Syndrome
New England Journal of Medicine · 19.11.2026 · 395 (20) · 2027-2042
DOI: 10.1056/nejmra2601172 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 19.11.2026. Verfasst von Carolyn S. Calfee und 1 weiteren Autor:innen. Die Arbeit nennt 96 Literaturangaben.
Abstract (Originalsprache)
Acute respiratory distress syndrome (ARDS) is a common cause of acute hypoxemic respiratory failure in patients with pneumonia, sepsis, aspiration of gastric contents, severe trauma, or other inciting triggers. Although the definition of the syndrome has evolved over the past several decades, the core elements (acute onset, hypoxemia, and bilateral radiographic opacities) remain consistent. Critical components of management include identification and treatment of the underlying cause of ARDS as well as avoidance of ventilator-induced lung injury and volume overload. Ongoing areas of controversy include the best strategy for supporting nonintubated patients, personalization of positive end-expiratory pressure, the role of innovative ventilatory strategies, and the use of glucocorticoids. New research suggests that precision medicine approaches to ARDS management that focus on discrete biologic, radiographic, or physiological subphenotypes may improve outcomes, and prospective trials of these approaches are ongoing.
Zitieren
APA
Calfee, C. S., & McAuley, D. F. (2026). Acute Respiratory Distress Syndrome. New England Journal of Medicine, 395(20), 2027-2042. https://doi.org/10.1056/nejmra2601172
Vancouver
Calfee CS, McAuley DF. Acute Respiratory Distress Syndrome. New England Journal of Medicine. 2026;395(20):2027-2042. doi:10.1056/nejmra2601172
BibTeX
@article{Calfee2026,
author = {Calfee, Carolyn S. and McAuley, Daniel F.},
title = {Acute Respiratory Distress Syndrome},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {20},
pages = {2027--2042},
doi = {10.1056/nejmra2601172}
}
EUVIMED